HebeCell
PrivateLast Round
Series A
Aug 31, 2021
Est. Valuation
$152.44M
Total Funding Raised
$68M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
HebeCell operates in Healthcare & Life Sciences and is based in Natick, Massachusetts. Its latest recorded funding round was a Series A round in August 2021.
HebeCell is a biotechnology company that develops cell-based therapeutics and manufacturing platforms for immuno-oncology and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Freemium
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HebeCell Comparables
Compare HebeCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoreline Biosciences | 86% | |
| Century Therapeutics | 80% | |
| Artiva | 79% |
For institutional investors. Book with your work email.
HebeCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 31, 2021 | ||||
| Pre Seed | Apr 24, 2020 |
For institutional investors. Book with your work email.
HebeCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Falcon Creek Capital | Series A |
| Fangyuan Capital (Hong Kong) Limited | Series A |
| Plaisance Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 51% MoM, from 806 to 1.2K.
- Jul 26, 2026
Monthly visitors increased 107% MoM, reaching 806.
For institutional investors. Book with your work email.
HebeCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HebeCell's valuation, stock price, and market status.
Is HebeCell a public or private company?
HebeCell is a private company.
What is the current stock price of HebeCell?
HebeCell is a private company, so its shares have no public market price. Caplight tracks HebeCell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HebeCell worth (valuation)?
HebeCell's valuation is estimated at $152.4M based on funding round data.
Can I buy HebeCell stock?
HebeCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HebeCell's last funding round?
HebeCell's most recent funding round was Series A on August 31, 2021.
Who are the main investors in HebeCell?
Key investors in HebeCell include Falcon Creek Capital.
Will HebeCell IPO soon?
No public IPO plans have been announced for HebeCell.
How can I track HebeCell secondary market activity?
Caplight tracks bids, offers, and trades in HebeCell's shares on secondary markets.